Types of Cancer We Treat

Prostate Cancer

Our nationally and internationally known specialists offer comprehensive services that include the most up-to-date, research-backed approaches to prostate cancer screening, diagnosis, treatment, post-treatment rehabilitation, and integrative therapies.

Our doctors share in the growing consensus among top prostate cancer specialists that many men are being overtreated for prostate cancer. We work together to identify which men are best served by aggressive treatment and which can be treated safely with a more conservative approach. We believe in empowering you with information, so that you can be an active partner in creating a personalized treatment plan that’s right for you.

Meet Our Doctors
Dr. Herbert Lepor
Diagnosis
Prostate Cancer Diagnosis
Active Surveillance
Prostate Cancer Active Surveillance
Surgery
Prostate Cancer Surgery
Radiation Therapy
Prostate Cancer Radiation Therapy
Minimally Invasive Ablation Treatment
Prostate Cancer Minimally Invasive Ablation Treatment
Hormone Therapies & Other Systemic Therapies
Prostate Cancer Hormone Therapies & Other Systemic Therapies

Related News

Encouraging Findings for Patients Undergoing Prostatectomy
Read Story
Deciding When to Treat Prostate Cancer
Read Story

Clinical Trials and Research Studies

Phase 1/2

A PHASE 1B/2 STUDY TO EVALUATE SAFETY AND ANTI-TUMOR ACTIVITY OF AVELUMAB IN COMBINATION WITH THE POLY (ADENOSINE DIPHOSPHATE [ADP]-RIBOSE) POLYMERASE (PARP) INHIBITOR TALAZOPARIB IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC SOLID TUMORS

Learn More

Phase 1

A Phase I Open Label Study of GSK3359609 Administered alone in Combination with Anticancer Agents in Subjects with Selected Advanced Solid Tumors

Learn More

Phase 1

A phase Ib open-label dose escalation and expansion study to investigate the safety pharmacokinetics pharmacodynamics and clinical activity of GSK525762 in combination with androgen deprivation therapy and other agents in subjects with castrate-resistant prostate cancer (CRPC)

Learn More

Phase 3

TRITON3: A Multicenter Randomized Open-label Phase 3 Study of Rucaparib versus Physician s Choice of Therapy for Patients with Metastatic Castration-resistant Prostate Cancer Associated with Homologous Recombination Deficiency

Learn More
View All Related Clinical Trials (6)